Harrow Health Valuation
| HROW Stock | USD 47.20 0.01 0.02% |
At this time, the firm appears to be undervalued. Harrow Health retains a regular Real Value of $54.02 per share. The prevalent price of the firm is $47.2. Our model calculates the value of Harrow Health from evaluating the firm fundamentals such as Current Valuation of 1.84 B, return on equity of -0.0957, and Return On Asset of 0.0491 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Harrow Health's valuation include:
Price Book 37.1588 | Enterprise Value | Enterprise Value Ebitda 48.8636 | Price Sales 6.9915 | Forward PE 43.6681 |
Undervalued
Today
Please note that Harrow Health's price fluctuation is very steady at this time. Calculation of the real value of Harrow Health is based on 3 months time horizon. Increasing Harrow Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Harrow stock is determined by what a typical buyer is willing to pay for full or partial control of Harrow Health. Since Harrow Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Harrow Stock. However, Harrow Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 47.2 | Real 54.02 | Target 70.63 | Hype 47.2 | Naive 47.61 |
The intrinsic value of Harrow Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Harrow Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Harrow Health helps investors to forecast how Harrow stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Harrow Health more accurately as focusing exclusively on Harrow Health's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Harrow Health's intrinsic value based on its ongoing forecasts of Harrow Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Harrow Health's closest peers.
Harrow Health Cash |
|
Harrow Revenue by Product
Harrow Health Total Value Analysis
Harrow Health is currently estimated to have valuation of 1.84 B with market capitalization of 1.75 B, debt of 228.83 M, and cash on hands of 51.7 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Harrow Health fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.84 B | 1.75 B | 228.83 M | 51.7 M |
Harrow Health Investor Information
About 16.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.13. Harrow Health had not issued any dividends in recent years. The entity had 1:5 split on the 8th of February 2013. Harrow Health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Harrow Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Harrow Health has an asset utilization ratio of 51.32 percent. This indicates that the Company is making $0.51 for each dollar of assets. An increasing asset utilization means that Harrow Health is more efficient with each dollar of assets it utilizes for everyday operations.Harrow Health Profitability Analysis
Considering the key profitability indicators obtained from Harrow Health's historical financial statements, Harrow Health may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Harrow Health's ability to earn profits and add value for shareholders.Net Loss | First Reported 2006-06-30 | Previous Quarter 5 M | Current Value 1 M | Quarterly Volatility 4.9 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.49 | 0.68 |
|
|
For Harrow Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Harrow Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Harrow Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Harrow Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Harrow Health over time as well as its relative position and ranking within its peers.
Harrow Health Earnings per Share Projection vs Actual
By analyzing Harrow Health's earnings estimates, investors can diagnose different trends across Harrow Health's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Harrow Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Harrow Health Ownership Allocation
Harrow Health has a total of 37.04 Million outstanding shares. Over half of Harrow Health's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Harrow Health Profitability Analysis
The company reported the previous year's revenue of 199.61 M. Net Loss for the year was (17.48 M) with profit before overhead, payroll, taxes, and interest of 186.44 M.About Harrow Health Valuation
Our relative valuation model uses a comparative analysis of Harrow Health. We calculate exposure to Harrow Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Harrow Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 172.9 M | 181.6 M | |
| Pretax Profit Margin | (0.08) | (0.08) | |
| Operating Profit Margin | 0.04 | 0.04 | |
| Net Loss | (0.08) | (0.08) | |
| Gross Profit Margin | 0.68 | 0.49 |
Harrow Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as Harrow Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 35.7 M | |
| Quarterly Earnings Growth Y O Y | -0.64 | |
| Forward Price Earnings | 43.6681 |
Harrow Health Current Valuation Indicators
Valuation refers to the process of determining the present value of Harrow Health and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Harrow we look at many different elements of the entity such as Harrow's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Harrow Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Harrow Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Harrow Health's worth.Additional Tools for Harrow Stock Analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.